Delayed graft function after kidney transplantation: The clinical perspective

American Journal of Kidney Diseases

Volumn 62, Issue 1, 2013, Pages 150-158

  Sharif, Adnan ^a   Borrows, Richard ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

acute kidney injury; Delayed graft function; donation after cardiac death; expanded criteria donor; machine perfusion; marginal kidneys; preservation solution

Indexed keywords

ACETYLCYSTEINE; ACTIVATED PROTEIN C; ALTEPLASE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CARBON MONOXIDE; CURCUMIN; CURCUMIN CYCLODEXTRIN COMPLEX; CYCLODEXTRIN; ECULIZUMAB; ENLIMOMAB; ERYTHROPOIETIN; ETANERCEPT; HYBRID PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METHYLPREDNISOLONE; PLACEBO; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT P SELECTIN GLYCOPROTEIN LIGAND IMMUNOGLOBULIN FUSION PROTEIN; RECOMBINANT PROTEIN; REPARIXIN; SMALL INTERFERING RNA; SMALL INTERFERING RNA I5NP; THEOPHYLLINE; THROMBOMODULIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CELL INTERACTION; CELL PROTECTION; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DRUG MEGADOSE; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOMODULATION; INNATE IMMUNITY; ISCHEMIC PRECONDITIONING; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; OBESITY; ORGAN PRESERVATION; PATHOPHYSIOLOGY; PERFUSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; RISK FACTOR;

EID: 84879419867     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.11.050     Document Type: Article

References (57)

1. A. Siedlecki, W. Irish, D.C. Brennan Delayed graft function in the kidney transplant Am J Transplant 11 2011 2279 2296
2. S.G. Yarlagadda, S.G. Coca, A.X. Garg Marked variation in the definition and diagnosis of delayed graft function: a systematic review Nephrol Dial Transplant 23 9 2008 2995 3003
3. S.K. Akkina, J.J. Connaire, A.K. Israni, J.J. Snyder, A.J. Matas, B.L. Kasiske Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance Am J Transplant 9 6 2009 1460 1466
4. J. Moore, S. Shabir, S. Chand Assessing and comparing rival definitions of delayed renal allograft function for predicting subsequent graft failure Transplantation 90 10 2010 1113 1116
5. S.G. Yarlagadda, S.G. Coca, R.N. Formica Jr, E.D. Poggio, C.R. Parikh Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis Nephrol Dial Transplant 24 3 2009 1039 1047
6. S.N. Tapiawala, K.J. Tinckam, C.J. Cardella Delayed graft function and the risk for death with a functioning graft J Am Soc Nephrol 21 1 2010 153 161
7. L.K. Kayler, T.R. Srinivas, J.D. Schold Influence of CIT-induced DGF on kidney transplant outcomes Am J Transplant 11 2011 2657 2664
8. W.H. Lim, S.P. McDonald, G.R. Russ Effect on graft and patient survival between shipped and locally transplant well-matched cadaveric renal allografts in Australia over a 10-year period Nephrology 11 2006 73 77
9. M.D. Stegall, P.G. Dean, M.A. McBride, J.J. Wynn Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era Transplantation 74 2002 670 675
10. D.M. Summers, R.J. Johnson, J. Allen Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study Lancet 376 2010 1303 1311
11. V. Schmitz, K.D. Schaser, P. Olschewski, P. Neuhaus, G. Puhl In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation Eur Surg Res 40 1 2008 19 25
12. W.H. Westendorp, H.G. Leuvenink, R.J. Ploeg Brain death induced renal injury Curr Opin Organ Transplant 16 2 2011 151 156
13. D.J. Kaczorowski, A. Tsung, T.R. Billiar Innate immune mechanisms in ischemia/reperfusion Front Biosci E1 2009 91 98
14. S. Rong, J.K. Park, T. Kirsch The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury J Am Soc Nephrol 22 3 2011 484 495
15. W.P. Pulskens, E. Rampanelli, G.J. Teske TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury J Am Soc Nephrol 21 8 2010 1299 1308
16. A. Eisenberg-Lerner, S. Bialik, H.U. Simon, A. Kimchi Life and death partners: apoptosis, autophagy and the cross-talk between them Cell Death Differ 16 2009 966 975
17. G. Kroemer, L. Galluzzi, P. Vandenabeele Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 Cell Death Differ 16 1 2009 3 11
18. A. Bajwa, G.R. Kinsey, M.D. Okusa Immune mechanisms and novel pharmacological therapies of acute kidney injury Curr Drug Targets 10 12 2009 1196 1204
19. B. Renner, D. Strassheim, C.R. Amura, L. Kulik, D. Ljubanovic, M.J. Glogowska B Cell subsets contribute to renal injury and renal protection after ischemia/reperfusion J Immunol 185 7 2010 4393 4400
20. W.D. Irish, J.N. Ilsley, M.A. Schnitzler, S. Feng, D.C. Brennan A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation Am J Transplant 10 10 2010 2279 2286
21. J.A. Lopes, F. Moreso, L. Rierra Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach Kidney Int 67 2005 1595 1600
22. M.G.J. Snoeijs, W.A. Buurman, M.H.L. Christiaans Histological assessment of preimplantation biopsies may improve selection of kidneys from old donors after cardiac death Am J Transplant 8 2008 1844 1851
23. T.F. Mueller, J. Reeve, G.S. Jhangri The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function Am J Transplant 8 1 2008 78 85
24. K.S. Famulski, D.G. de Freitas, C. Kreepala Molecular phenotypes of acute kidney injury in kidney transplants J Am Soc Nephrol 23 2012 948 958
25. C.R. Parikh, A. Jani, J. Mishra Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation Am J Transplant 6 7 2006 1639 1645
26. I.E. Hall, S.G. Yarlagadda, S.G. Coca IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation J Am Soc Nephrol 21 1 2010 189 197
27. C. Moers, O.C. Varnav, E. van Heurn The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome Transplantation 90 9 2010 966 973
28. C. Moers, J.M. Smits, M.H. Maathuis Machine perfusion or cold storage in deceased-donor kidney transplantation N Engl J Med 360 1 2009 7 19
29. J. Treckmann, C. Moers, J.M. Smits Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death Transpl Int 24 2011 548 554
30. I. Jochmans, C. Moers, J.M. Smits Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized controlled trial Ann Surg 252 2010 756 764
31. I. Abboud, C. Antoine, T. Serrato Pulsatile perfusion preservation for expanded-criteria donors kidneys: Impact on delayed graft function Transpl Int 24 suppl 2 2011 52
32. C.J. Watson, A.C. Wells, R.J. Roberts Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial Am J Transplant 10 9 2010 1991 1999
33. J.M. O'Callaghan, S.R. Knight, R.D. Morgan, P.J. Morris Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis Am J Transplant 12 4 2012 896 906
34. P. Schnuelle, U. Gottmann, S. Hoeger Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial JAMA 302 10 2009 1067 1075
35. I.R. Shilliday, M. Sherif Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients Cochrane Database Syst Rev 4 2007 CD003421
36. A. Sharif, S. Shabir, S. Chand, P. Cockwell, S. Ball, R. Borrows Meta-analysis of calcineurin inhibitors in kidney transplantation J Am Soc Nephrol 22 11 2011 2107 2118
37. A.O. Gaber, S. Mulgaonkar, B.D. Kahan YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study Clin Transplant 25 4 2011 523 533
38. N. Bonneyfoy-Berard, C. Vincent, J.-P. Revillard Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins Transplantation 51 3 1991 669 673
39. W.C. Goggins, M.A. Pascual, J.A. Powelson A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients Transplantation 76 5 2003 798 802
40. A. Kainz, J. Wilflingseder, C. Mitterbauer Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial Ann Intern Med 153 4 2010 222 230
41. K. Salmela, L. Wramner, H. Ekberg A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Syudy Group Transplantation 67 1999 729 736
42. M. Cooper, S. Kapur, R. Stratta Diannexin, a novel ischemia/reperfusion therapeutic agent, reduces delayed graft function in renal transplant recipients from marginal donors Am J Transplant 10 suppl 2010 S83
43. F. Martinez, N. Kamar, N. Pallet High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: results of the Neo-PDGF Study Am J Transplant 10 7 2010 1695 1700
44. K.K. Sureshkumar, S.M. Hussain, T.Y. Ko, N.L. Thai, R.J. Marcus Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial J Am Soc Nephrol 7 2012 1498 1506
45. Z. Aydin, M.J. Mallat, A.F. Schaapherder Randomized trial of short-course high-dose erythropoietin in donation after cardiac death kidney transplant recipients Am J Transplant 12 7 2012 1793 1800
46. deFreitas D, Coupes B, Hoyle D, et al. Effect of high-dose erythropoetin on early graft outcomes in NHBD and ECD kidney recipients: a randomised, placebo-controlled trial. Oral presentation at British Transplantation Society 13th Annual Congress, June 2009, London, United Kingdom.
47. Z. Kikic, M. Lorenz, G. Sunder-Plassmann Effect of hemodialysis before transplant surgery on renal allograft function - a pair of randomized controlled trials Transplantation 88 2009 1377 1385
48. M.G. Snoeijs, A.J. Dekkers, W.A. Buurman In situ preservation of kidneys from donors after cardiac death: results and complications Ann Surg 246 5 2007 844 852
49. A.C. Farney, R.P. Singh, M.H. Hines Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support J Am Coll Surg 206 5 2008 1028 1037
50. S.A. Hosgood, H.F.L. Nicholson, M.L. Nicholson Oxygentaed kidney preservation techniques Transplantation 93 2012 455 459
51. S.A. Hosgood, M.L. Nicholson First in man renal transplantation after ex-vivo normothermic perfusion Transplantation 92 2011 735 738
52. M. Morigi, M. Introna, B. Imberti Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice Stem Cells 26 8 2008 2075 2082
53. Y. Wang, E. Bakota, B.H. Chang, M. Entman, J.D. Hartgerink, F.R. Danesh Peptide nanofibers preconditioned with stem cell secretome are renoprotective J Am Soc Nephrol 22 4 2011 704 717
54. S. Bruno, C. Grange, M.C. Deregibus Mesenchymal stem cell-derived microvesicles protect against acute tubular injury J Am Soc Nephrol 20 5 2009 1053 1067
55. A. Schulze, J. Downward Navigating gene expression using microarrays - a technology review Nat Cell Biol 3 2001 E190 E195
56. D. Murphy Gene expression studies using microarrays: principles, problems, and prospects Adv Physiol Educ 26 2002 256 270
57. N. Chatauret, R. Thuillier, T. Hauet Preservation strategies to reduce ischemic injury in kidney transplantation: pharmacological and genetic approaches Curr Opin Organ Transplant 16 2 2011 180 187